Welcome to the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)

The FMP conducts basic research in Molecular Pharmacology with the aim to identify novel bioactive molecules and to characterize their interactions with their biological targets in cells or organisms. Read more

Research Highlights

A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder. Scientists from the…

Read more

Given that phages are able to destroy bacteria, they are of particular interest to science. Basic researchers from the Leibniz-Forschungsinstitut für…

Read more

It appears that autophagy protects our neurons in the brain, but evidently for entirely different reasons than previously assumed, as researchers from…

Read more

Cellular waste disposal, where autophagy and lysosomes interact, performs elementary functions, such as degrading damaged protein molecules, which…

Read more

IMMUNITY VRAC/LRRC8 chloride channels do not only play a decisive role in the transport of cytostatics, amino acids and neurotransmitters. They can…

Read more

Since April 27 the scientists are working in a low contact basic operation mode

During this time, the following rules apply:

  • All researchers and administration employees work in a low contact basic operation mode.
  • All others work mobile.
  • Suppliers and employees of service companies please register by telephone with their FMP contact persons.

 

Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)
info(at)fmp-berlin.de

Like many sites, we use cookies to optimize the user's browsing experience. Data Protection OK